Excited to share our new preprint on bacteriophage engineering 🦠 🎨

https://www.biorxiv.org/content/10.64898/2026.02.20.706991v1

We establish a genomics-guided approach for inferring receptor-binding protein compatibility, which may guide host retargeting of therapeutic bacteriophage scaffolds. #AMR, #phagetherapy

For the FOSS-minded folks here: we also released the R package tailor which we used for key parts of the analysis: https://github.com/sbthandras/tailor

A global map of receptor-binding protein compatibility for the programmable design of Klebsiella and Acinetobacter phages

The narrow host range of bacteriophages limits their application against genetically diverse bacteria, motivating rational host-range modification. Progress in programmable engineering depends on establishing design principles that determine the compatibility of possible host-recognition modules with phage scaffolds. Here, we establish a genomics-guided framework that systematically identifies compatibility-determining adapter domains in receptor-binding proteins for the rational engineering of phages to target clinically relevant pathogen populations. Applying this approach to 1,270 phage genomes infecting Acinetobacter baumannii and Klebsiella pneumoniae, we show that viral diversity is highly structured: 60% of the 2,313 receptor-binding proteins group into only 19 major clusters sharing conserved N-terminal compatibility adapters. The structurally most conserved adapters in Autographivirales are associated with diverse capsule-degrading depolymerases. Known host-specificities within single-adapter clusters target capsule types that represent up to 29% of A. baumannii and 44% of K. pneumoniae carbapenem-resistant populations. Overall, we define a global repertoire of modular host-recognition components for programmable configuration of phage therapeutics. ### Competing Interest Statement Balint Kintses is the founder of SplitPhage Solutions Ltd. and a shareholder in BRC-Bio Ltd., companies operating in the field of biotechnology. These companies had no role in the design, execution, interpretation, or funding of this study. National Research, Development and Innovation Fund ADVANCED, 149516 2024-1.2.2-ERA_NET-2024-00004 grant the National Laboratory of Biotechnology grant, 2022-2.1.1-NL-2022-00008 the National Laboratory for Health Security grant, RRF-2.3.1-21-2022-00006 the HUN-REN TKCS-2024/66 grant the Ministry of Culture and Innovation of Hungary grant KDP-2023-C2285907, financed under the National Research, Development and Innovation Fund, 2023-2.1.2-KDP-2023-00002 the European Union’s Horizon 2020 Research and Innovation Programme, 739593

bioRxiv

Sulla Stazione Spaziale Internazionale i virus evolvono diversamente: lo studio che apre nuove strade contro i batteri resistenti

https://fed.brid.gy/r/https://www.galaxyaddicted.it/2026/01/virus-batteri-microgravita-iss/

Interesting.

BBC News: I found a bacteria-eating #virus in my loo - could it save your life?

#bacteria #phage #PhageTherapy #antibiotics

https://www.bbc.com/news/articles/czryvm3nlvdo

Phage therapy: I found a bacteria-eating virus in my loo

It's hoped phages could give us new ways of treating infections which are immune to antibiotics.

Habt ihr schonmal von Phagen (Therapie) gehört?

Ich find das so mindblowing, es hat viel Potenzial im Kontext von Antibiotikaresistenzen (Krise).

https://pubmed.ncbi.nlm.nih.gov/39976508/

…auch bezeichnend warum die amerikanisch, europäische Forschung das jetzt erst richtig aktiv angeht

#Phagentherapie #phagetherapy

Unveiling the potential bacteriophage therapy: a systematic review - PubMed

This study emphasizes the promise of phage therapy as a safe and efficient treatment for bacterial-illnesses. Despite its potential, there are still significant gaps in clinical application, long-term efficacy assessment, and trial standardization. Addressing these issues is critical to developing p …

PubMed

How did a cholera strain outwit viruses and ignite a major epidemic? The answer could redefine outbreak control. #cholera #phagetherapy #microbialdefense

https://geekoo.news/how-cholera-outsmarts-its-viral-predators/

How Cholera Outsmarts Its Viral Predators | Geekoo

EPFL researchers have decoded how cholera bacteria used viral immunity to fuel a deadly epidemic—reshaping our understanding of outbreaks and the future of phage therapy.

Geekoo

The Wildest Credible Ideas to Overcome Our Antibiotics Problems

The fight against antibiotic resistance is getting wild!

From phage therapy to microbiome manipulation, scientists are thinking outside the box.

What if these crazy ideas actually work? 🤔

Substack Podcast Version: tinyurl.com/29rz5t96

Youtube: youtu.be/c0FTHS244Cg

Home Base: airoad.substack.com

#AntibioticResistance #PhageTherapy #Antibiotics #Science

Unveiling bacteria's hidden defenses against viruses: Could this be the key to overcoming antibiotic resistance? Discover the groundbreaking research. #AntibioticResistance #Microbiology #PhageTherapy

https://geekoo.news/bacterias-secret-weapon-against-viruses-a-new-clue-in-combating-antibiotic-resistance/

Bacteria's Secret Weapon Against Viruses: A New Clue in Combating Antibiotic Resistance | Geekoo

Scientists at Umeå University have uncovered a novel bacterial defense mechanism against viruses, offering fresh insights into the battle against antibiotic resistance.

Geekoo
The first case of phage therapy for biliary tract infection caused by superbugs!

Biliary tract infections (BTI), often linked to structural abnormalities like bile duct stones, pose significant treatment challenges due to drug-resistant bacteria like Pseudomonas aeruginosa. Phage therapy, which uses viruses to target bacteria, has emerged as a promising solution. This study by researchers from Fudan University and Army Medical University, published in hLife, reported the first successful use of personalized phage therapy for chronic BTI caused by multidrug-resistant P. aeruginosa. An 88-year-old patent with recurrent infections underwent phage therapy after traditional treatments failed. A customized phage cocktail was administered, leading to symptom improvement and reduced bacterial load. However, phage-resistant strains emerged, prompting a second round of therapy with a different phage, which further alleviated symptoms. Genomic analysis revealed bacterial mutations contributing to resistance. This study highlights the potential of phage therapy for treating drug-resistant infections, though challenges like bacterial heterogeneity and biofilm formation remain. Future research aims to optimize phage therapy strategies for better outcomes.

EurekAlert!

"A century-old treatment that uses viruses to attack bacteria was successfully used in 2024 to save the life of a Singapore General Hospital (SGH) patient who had exhausted all care options for an antibiotic-resistant infection.

This made her the first patient in South-east Asia to benefit from phage therapy"

https://www.straitstimes.com/singapore/health/century-old-therapy-used-to-treat-sgh-patient-with-antibiotic-resistant-infection

#Bacteriophages #Health #Medicine #Singapore #Bacteria #PhageTherapy

Century-old therapy used to treat SGH patient with antibiotic-resistant infection

Known as phage therapy, it uses viruses to kill harmful bacteria in difficult-to-treat infections. Read more at straitstimes.com.

The Straits Times